L-NIO dihydrochloride - CAS 159190-44-0
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C7H15N3O2.2HCl
Molecular Weight:
246.13
COA:
Inquire
Targets:
Nitric oxide synthase (NOS)
Description:
L-NIO dihydrochloride is a nitric oxide synthase inhibitor. It can inhibit iNOS, eNOS and nNOS. Active in vivo.
Purity:
≥95% by HPLC
Synonyms:
N5-(1-Iminoethyl)-L-ornithine dihydrochloride
MSDS:
Inquire
InChIKey:
RYCMAAFECCXGHI-ILKKLZGPSA-N
InChI:
InChI=1S/C7H15N3O2.2ClH/c1-5(8)10-4-2-3-6(9)7(11)12;;/h6H,2-4,9H2,1H3,(H2,8,10)(H,11,12);2*1H/t6-;;/m0../s1
Canonical SMILES:
CC(=NCCCC(C(=O)O)N)N.Cl.Cl
1.Mercaptopyruvate acts as endogenous vasodilator independently of 3-mercaptopyruvate sulfurtransferase activity.
Mitidieri E;Tramontano T;Gurgone D;Citi V;Calderone V;Brancaleone V;Katsouda A;Nagahara N;Papapetropoulos A;Cirino G;d'Emmanuele di Villa Bianca R;Sorrentino R Nitric Oxide. 2018 May 1;75:53-59. doi: 10.1016/j.niox.2018.02.003. Epub 2018 Feb 13.
Hydrogen sulfide (H;2;S) is produced by the action of cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE) or 3-mercaptopyruvate sulfurtransferase (3-MST). 3-MST converts 3-mercaptopyruvate (MPT) to H;2;S and pyruvate. H;2;S is recognized as an endogenous gaseous mediator with multiple regulatory roles in mammalian cells and organisms. In the present study we demonstrate that MPT, the endogenous substrate of 3-MST, acts also as endogenous H;2;S donor. Colorimetric, amperometric and fluorescence based assays demonstrated that MPT releases H;2;S in vitro in an enzyme-independent manner. A functional study was performed on aortic rings harvested from C57BL/6 (WT) or 3-MST-knockout (3-MST;-/-;) mice with and without endothelium. MPT relaxed mouse aortic rings in endothelium-independent manner and at the same extent in both WT and 3-MST;-/-; mice. N5-(1-Iminoethyl)-l-ornithine dihydrochloride (L-NIO, an inhibitor of endothelial nitric oxide synthase) as well as 1H-[1,2,4]oxadiazolo [4,3-a]quinoxalin-1-one (ODQ, a soluble guanylyl cyclase inhibitor) did not affect MPT relaxant action. Conversely, hemoglobin (as H;2;S scavenger), as well as glybenclamide (an ATP-dependent potassium channel blocker) markedly reduced MPT-induced relaxation.
2.Increase in Red Blood Cell-Nitric Oxide Synthase Dependent Nitric Oxide Production during Red Blood Cell Aging in Health and Disease: A Study on Age Dependent Changes of Rheologic and Enzymatic Properties in Red Blood Cells.
Bizjak DA;Brinkmann C;Bloch W;Grau M PLoS One. 2015 Apr 22;10(4):e0125206. doi: 10.1371/journal.pone.0125206. eCollection 2015.
AIM: ;To investigate RBC-NOS dependent NO signaling during in vivo RBC aging in health and disease.;METHOD: ;RBC from fifteen healthy volunteers (HC) and four patients with type 2 diabetes mellitus (DM) were separated in seven subpopulations by Percoll density gradient centrifugation.;RESULTS: ;The proportion of old RBC was significantly higher in DM compared to HC. In both groups, in vivo aging was marked by changes in RBC shape and decreased cell volume. RBC nitrite, as marker for NO, was higher in DM and increased in both HC and DM during aging. RBC deformability was lower in DM and significantly decreased in old compared to young RBC in both HC and DM. RBC-NOS Serine1177 phosphorylation, indicating enzyme activation, increased during aging in both HC and DM. Arginase I activity remained unchanged during aging in HC. In DM, arginase I activity was significantly higher in young RBC compared to HC but decreased during aging. In HC, concentration of L-arginine, the substrate of RBC-NOS and arginase I, significantly dropped from young to old RBC. In DM, L-arginine concentration was significantly higher in young RBC compared to HC and significantly decreased during aging. In blood from healthy subjects, RBC-NOS activation was additionally inhibited by N5-(1-iminoethyl)-L-Ornithine dihydrochloride which decreased RBC nitrite, and impaired RBC deformability of all but the oldest RBC subpopulation.
3.The Nitric oxide/CGMP/KATP pathway mediates systemic and central antinociception induced by resistance exercise in rats.
Galdino GS;Xavier CH;Almeida R;Silva G;Fontes MA;Menezes G;Duarte ID;Perez AC Int J Neurosci. 2015;125(10):765-73. doi: 10.3109/00207454.2014.970256. Epub 2014 Oct 29.
Resistance exercise (RE) is characterized to increase strength, tone, mass, and/or muscular endurance and also for produces many beneficial effects, such as blood pressure and osteoporosis reduction, diabetes mellitus control, and analgesia. However, few studies have investigated endogenous mechanisms involved in the RE-induced analgesia. Thus, the aim of this study was evaluate the role of the NO/CGMP/KATP pathway in the antinociception induced by RE. Wistar rats were submitted to acute RE in a weight-lifting model. The nociceptive threshold was measured by mechanical nociceptive test (paw-withdrawal). To investigate the involvement of the NO/CGMP/KATP pathway the following nitric oxide synthase (NOS) non-specific and specific inhibitors were used: N-nitro-l-arginine (NOArg), Aminoguanidine, N5-(1-Iminoethyl)-l-ornithine dihydrocloride (l-NIO), Nω-Propyl-l-arginine (l-NPA); guanylyl cyclase inhibitor, 1H-[1,2,4]oxidiazolo[4,3-a]quinoxalin-1-one (ODQ); and KATP channel blocker, Glybenclamide; all administered subcutaneously, intrathecally and intracerebroventricularly. Plasma and cerebrospinal fluid (CSF) nitrite levels were determined by spectrophotometry. The RE protocol produced antinociception, which was significantly reversed by NOS specific and unspecific inhibitors, guanylyl cyclase inhibitor (ODQ) and KATP channel blocker (Glybenclamide).
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Nitric oxide synthase (NOS) Products


CAS 214358-33-5 1400W dihydrochloride

1400W dihydrochloride
(CAS: 214358-33-5)

1400W is a selective inducible nitric oxide synthase (NOS) inhibitor(Ki=7nM).By suppressing the induction of inducible NOS, 1400W exhibits an therapeutical effe...

FK-330
(CAS: 442198-67-6)

FK-330 is a novel inducible nitric oxide synthase inhibitor for preventing ischemia and reperfusion injury in rat liver transplantation.

CAS 2219-31-0 L-Canavanine sulfate

L-Canavanine sulfate
(CAS: 2219-31-0)

The sulfate salt form of L-Canavanine, a homoserine analog, has been found to be a NO synthase inhibitor.

CAS 62949-77-3 Kuwanon A

Kuwanon A
(CAS: 62949-77-3)

Kuwanon A, a flavone derivative isolated from the root barks of the mulberry tree (Morus alba L.), inhibits nitric oxide production (IC50= 10.5 μM).

Cindunistat hydrochloride maleate
(CAS: 753491-31-5)

Cindunistat is a selective Nitric oxide synthase (iNOS) type II inhibitor. It is potentially useful in patients with symptomatic osteoarthritis of the knee. But...

CAS 4269-97-0 S-Isopropylisothiourea hydrobromide

S-Isopropylisothiourea hydrobromide
(CAS: 4269-97-0)

S-Isopropylisothiourea hydrobromide is the hydrobromide form of S-Isopropylisothiourea, which is a potent non-selective nitric oxide synthase (NOS) inhibitor. I...

CAS 16011-96-4 2-Iminopiperidine hydrochloride

2-Iminopiperidine hydrochloride
(CAS: 16011-96-4)

2-Iminopiperidine hydrochloride is the hydrochloride salt of 2-Iminopiperidine, which is a potent inhibitor of human nitric oxide synthase isoform (iNOS). It is...

CAS 210354-22-6 GW 274150

GW 274150
(CAS: 210354-22-6)

GW 274150 is a potent, long-acting and highly selective inhibitor of iNOS which have a very high degree of selectivity for iNOS versus both eNOS (>100-fold) and...

Chemical Structure

CAS 159190-44-0 L-NIO dihydrochloride

Quick Inquiry

Verification code

Featured Items